These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 21890077)

  • 1. Comparison of bare-metal and drug-eluting stents in patients with chronic kidney disease (from the NHLBI Dynamic Registry).
    Green SM; Selzer F; Mulukutla SR; Tadajweski EJ; Green JA; Wilensky RL; Laskey WK; Cohen HA; Rao SV; Weisbord SD; Lee JS; Reis SE; Kip KE; Kelsey SF; Williams DO; Marroquin OC
    Am J Cardiol; 2011 Dec; 108(11):1658-64. PubMed ID: 21890077
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Drug-Eluting Versus Bare-Metal Stents During PCI in Patients With End-Stage Renal Disease on Dialysis.
    Chang TI; Montez-Rath ME; Tsai TT; Hlatky MA; Winkelmayer WC
    J Am Coll Cardiol; 2016 Mar; 67(12):1459-1469. PubMed ID: 27012407
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Renal function and effect of statin therapy on cardiovascular outcomes in patients undergoing coronary revascularization (from the CREDO-Kyoto PCI/CABG Registry Cohort-2).
    Natsuaki M; Furukawa Y; Morimoto T; Sakata R; Kimura T;
    Am J Cardiol; 2012 Dec; 110(11):1568-77. PubMed ID: 22935527
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chronic Kidney Disease in the Second-Generation Drug-Eluting Stent Era: Pooled Analysis of the Korean Multicenter Drug-Eluting Stent Registry.
    Lee JM; Kang J; Lee E; Hwang D; Rhee TM; Park J; Kim HL; Lee SE; Han JK; Yang HM; Park KW; Na SH; Kang HJ; Koo BK; Kim HS
    JACC Cardiovasc Interv; 2016 Oct; 9(20):2097-2109. PubMed ID: 27692820
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Outcomes of small coronary artery stenting with bare-metal stents versus drug-eluting stents: results from the NHLBI Dynamic Registry.
    Parikh SV; Luna M; Selzer F; Marroquin OC; Mulukutla SR; Abbott JD; Holper EM
    Catheter Cardiovasc Interv; 2014 Feb; 83(2):192-200. PubMed ID: 21735515
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Safety and efficacy of drug-eluting stents in older patients with chronic kidney disease: a report from the linked CathPCI Registry-CMS claims database.
    Tsai TT; Messenger JC; Brennan JM; Patel UD; Dai D; Piana RN; Anstrom KJ; Eisenstein EL; Dokholyan RS; Peterson ED; Douglas PS
    J Am Coll Cardiol; 2011 Oct; 58(18):1859-69. PubMed ID: 22018296
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of three age groups regarding safety and efficacy of drug-eluting stents (from the National Heart, Lung, and Blood Institute Dynamic Registry).
    Bainey KR; Selzer F; Cohen HA; Marroquin OC; Holper EM; Graham MM; Williams DO; Faxon DP
    Am J Cardiol; 2012 Jan; 109(2):195-201. PubMed ID: 22000774
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative Efficacy of Coronary Revascularization Procedures for Multivessel Coronary Artery Disease in Patients With Chronic Kidney Disease.
    Roberts JK; Rao SV; Shaw LK; Gallup DS; Marroquin OC; Patel UD
    Am J Cardiol; 2017 May; 119(9):1344-1351. PubMed ID: 28318510
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of bare-metal stents and drug-eluting stents in coronary ostial lesions (from the National Heart, Lung, and Blood Institute Dynamic Registry).
    Vasaiwala S; Vlachos H; Selzer F; Marroquin O; Mulukutla S; Abbott JD; Williams DO
    Am J Cardiol; 2012 Oct; 110(8):1113-8. PubMed ID: 22762712
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of Chronic Kidney Disease on Cardiovascular and Renal Events in Patients Undergoing Percutaneous Coronary Intervention with Everolimus-Eluting Stent: Risk Stratification with C-Reactive Protein.
    Dan K; Miyoshi T; Nakahama M; Mizuno T; Kagawa K; Naito Y; Kawada S; Ito H
    Cardiorenal Med; 2018; 8(2):151-159. PubMed ID: 29617004
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of drug-eluting stents among insulin-treated diabetic patients: a report from the National Heart, Lung, and Blood Institute Dynamic Registry.
    Mulukutla SR; Vlachos HA; Marroquin OC; Selzer F; Holper EM; Abbott JD; Laskey WK; Williams DO; Smith C; Anderson WD; Lee JS; Srinivas V; Kelsey SF; Kip KE
    JACC Cardiovasc Interv; 2008 Apr; 1(2):139-47. PubMed ID: 19212456
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Drug-eluting stents versus bare-metal stents in patients with decreased GFR: a meta-analysis.
    Wang ZJ; Harjai KJ; Shenoy C; Gao F; Shi DM; Liu YY; Zhao YX; Zhou YJ
    Am J Kidney Dis; 2013 Oct; 62(4):711-21. PubMed ID: 23773369
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term benefits and risks of drug-eluting compared to bare-metal stents in patients with versus without chronic kidney disease.
    Wanitschek M; Pfisterer M; Hvelplund A; De Servi S; Bertel O; Jeger R; Rickenbacher P; Iversen A; Jensen JS; Galatius S; Kaiser C; Alber H;
    Int J Cardiol; 2013 Oct; 168(3):2381-8. PubMed ID: 23453439
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evolution in practice patterns and long-term outcomes of coronary revascularization from bare-metal stent era to drug-eluting stent era in Japan.
    Shiomi H; Morimoto T; Makiyama T; Ono K; Furukawa Y; Nakagawa Y; Kadota K; Onodera T; Takatsu Y; Mitsudo K; Kita T; Sakata R; Okabayashi H; Hanyu M; Komiya T; Yamazaki F; Nishiwaki N; Kimura T;
    Am J Cardiol; 2014 May; 113(10):1652-9. PubMed ID: 24792736
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Short and long term outcome of percutaneous coronary intervention with drug eluting stent and bare metal stent in patients with chronic kidney disease.
    Resmini C; Di Cuia M; Ballocca F; D'Ascenzo F; Bollati M; Moretti C; Omedè PL; Sciuto F; Gaita F; Sheiban I
    Minerva Cardioangiol; 2012 Dec; 60(6):573-80. PubMed ID: 23147435
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical outcomes following percutaneous coronary intervention with drug-eluting vs. bare-metal stents in dialysis patients.
    Halkin A; Selzer F; Marroquin O; Laskey W; Detre K; Cohen H
    J Invasive Cardiol; 2006 Dec; 18(12):577-83. PubMed ID: 17197706
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of Drug-Eluting and Bare Metal Stents in Patients With Chronic Kidney Disease: An Updated Systematic Review and Meta-Analysis.
    Lu R; Tang F; Zhang Y; Zhu X; Zhu S; Wang G; Jiang Y; Fan Z
    J Am Heart Assoc; 2016 Nov; 5(11):. PubMed ID: 27821401
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Revascularization in Patients With Multivessel Coronary Artery Disease and Chronic Kidney Disease: Everolimus-Eluting Stents Versus Coronary Artery Bypass Graft Surgery.
    Bangalore S; Guo Y; Samadashvili Z; Blecker S; Xu J; Hannan EL
    J Am Coll Cardiol; 2015 Sep; 66(11):1209-1220. PubMed ID: 26361150
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Outcomes following coronary stenting in the era of bare-metal vs the era of drug-eluting stents.
    Malenka DJ; Kaplan AV; Lucas FL; Sharp SM; Skinner JS
    JAMA; 2008 Jun; 299(24):2868-76. PubMed ID: 18577731
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk of death and myocardial infarction in patients with peripheral arterial disease undergoing percutaneous coronary intervention (from the National Heart, Lung and Blood Institute Dynamic Registry).
    Parikh SV; Saya S; Divanji P; Banerjee S; Selzer F; Abbott JD; Naidu SS; Wilensky RL; Faxon DP; Jacobs AK; Holper EM
    Am J Cardiol; 2011 Apr; 107(7):959-64. PubMed ID: 21256469
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.